Sigilon Therapeutics, Inc. Current Ratio 2021-2023 | SGTX
Sigilon Therapeutics, Inc. current ratio from 2021 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-06-30 | $0.05B | $0.03B | 1.78 |
| 2023-03-31 | $0.07B | $0.03B | 2.23 |
| 2022-12-31 | $0.07B | $0.03B | 2.40 |
| 2022-09-30 | $0.08B | $0.03B | 2.64 |
| 2022-06-30 | $0.09B | $0.03B | 2.77 |
| 2022-03-31 | $0.11B | $0.04B | 2.96 |
| 2021-12-31 | $0.13B | $0.04B | 3.62 |
| 2021-09-30 | $0.14B | $0.04B | 3.52 |
| 2021-06-30 | $0.17B | $0.04B | 3.75 |
| 2021-03-31 | $0.18B | $0.03B | 5.31 |
| 2020-12-31 | $0.20B | $0.05B | 4.34 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
